Therapeutic Targeting of Misfolding and Conformational Change in α 1 -Antitrypsin Deficiency
Authors:
- 1 June 2014
- journal article
- review article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 6 (9) , 1047-1065
Abstract
Misfolding and conformational diseases are increasing in prominence and prevalence. Both misfolding and 'postfolding' conformational mechanisms can contribute to pathogenesis and can coexist. The different contexts of folding and native state behavior may have implications for the development of therapeutic strategies. α1-antitrypsin deficiency illustrates how these issues can be addressed with therapeutic approaches to rescue folding, ameliorate downstream consequences of aberrant polymerization and/or maintain physiological function. Small-molecule strategies have successfully targeted structural features of the native conformer. Recent developments include the capability to follow solution behavior of α1-antitrypsin in the context of disease mutations and interactions with drug-like compounds. Moreover, preclinical studies in cells and organisms support the potential of manipulating cellular response repertoires to process misfolded and polymer states.Keywords
Funding Information
- Alpha-1 Foundation
This publication has 139 references indexed in Scilit:
- Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha‐1‐anti‐trypsin deficiencyEMBO Molecular Medicine, 2013
- Structural Dynamics Associated with Intermediate Formation in an Archetypal Conformational DiseaseStructure, 2012
- Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cellsNature, 2011
- Generation of Transgene-Free Lung Disease-Specific Human Induced Pluripotent Stem Cells Using a Single Excisable Lentiviral Stem Cell CassetteStem Cells, 2010
- Sec61p is part of the endoplasmic reticulum‐associated degradation machineryThe EMBO Journal, 2009
- Single nucleotide polymorphism–mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in alpha1-antitrypsin deficiency #Hepatology, 2009
- Crystallographic and Cellular Characterisation of Two Mechanisms Stabilising the Native Fold of α1-Antitrypsin: Implications for Disease and Drug DesignJournal of Molecular Biology, 2009
- Small Molecules Block the Polymerization of Z α1-Antitrypsin and Increase the Clearance of Intracellular AggregatesJournal of Medicinal Chemistry, 2007
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Hormone binding globulins undergo serpin conformational change in inflammationNature, 1988